Orforglipron (NEW) with Chromium Picolinate 1mg / 2.5mg (30 Capsules)

Clinical Formulary · MP-ORF-CAP-25

Orforglipron (NEW) with Chromium Picolinate 1mg / 2.5mg (30 Capsules)

Orforglipron 1mg/2.5mg capsules — 30 count, titration strength.

$130.00Professional Use OnlyIn Stock

SKU

MP-ORF-CAP-25

Form

glp capsules

Category

glp weight loss capsules

Status

In Stock

Orforglipron (NEW) with Chromium Picolinate 1mg / 2.5mg (30 Capsules)

SKU: MP-ORF-CAP-25

Order This Product

Orforglipron 1mg/2.5mg capsules — 30 count, titration strength.

Orforglipron (NEW) oral capsule — titrate to next strength per clinic schedule after tolerance confirmed.

Key Benefits

  • Novel oral GLP-1 RA
  • 2.5mg titration dose
  • 30 capsules
  • Clinic-supervised escalation

Orforglipron oral capsule at 2.5mg strength for patients advancing through clinic titration protocols.

$130.00

Professional clinical use only. Terms & conditions apply.

Product Solution Guide

Clinical Use & Administration

Non-injection weight management option for patients suited to oral daily dosing under clinical monitoring.

Follow your clinic's approved protocol. Steps below are general guidance for qualified practitioners.

  1. 1

    Select Strength

    Dispense the physician-prescribed strength (listed on bottle label). Match capsule strength to current titration phase of patient protocol.

  2. 2

    Daily Oral Dose

    Patient takes one capsule daily with a full glass of water, preferably at the same time each day. May take with or without food per clinic protocol.

  3. 3

    Titration Schedule

    Advance to next strength tier only per physician-directed schedule — typically after 4–8 weeks at current dose if tolerated.

  4. 4

    Monitor & Reorder

    Track 30-day supply per bottle. Schedule follow-up before bottle completion to avoid treatment gaps.

Clinic Ordering Notes

Order by strength tier. Multi-strength inventory recommended for active titration clinics.

Build Your Goal